[YTL] QoQ Annualized Quarter Result on 30-Sep-2015 [#1]

Stock
[YTL] YTL CORPORATION BHD
Announcement Date
26-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2016
Quarter
30-Sep-2015 [#1]
Profit Trend
QoQ- -20.36%
YoY- -6.25%
Quarter Report
Latest QR
Upcoming QR
YTL's Result
YTL's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 15,377,505 16,006,040 16,773,570 17,793,556 16,754,726 16,941,097 17,411,276 -7.95%
PBT 2,262,531 2,078,736 2,139,400 2,866,408 2,323,337 2,461,065 2,449,350 -5.15%
Tax -375,573 -517,794 -594,938 -1,589,164 -602,305 -692,290 -585,250 -25.62%
NP 1,886,958 1,560,941 1,544,462 1,277,244 1,721,032 1,768,774 1,864,100 0.81%
-
NP to SH 916,431 889,886 875,074 810,460 1,017,645 1,027,742 1,075,270 -10.11%
-
Tax Rate 16.60% 24.91% 27.81% 55.44% 25.92% 28.13% 23.89% -
Total Cost 13,490,547 14,445,098 15,229,108 16,516,312 15,033,694 15,172,322 15,547,176 -9.03%
-
Net Worth 14,580,347 13,952,202 14,376,216 15,770,548 14,582,559 14,108,984 13,673,954 4.37%
Dividend
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Div 989,380 - - - 989,530 - - -
Div Payout % 107.96% - - - 97.24% - - -
Equity
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Net Worth 14,580,347 13,952,202 14,376,216 15,770,548 14,582,559 14,108,984 13,673,954 4.37%
NOSH 10,414,534 10,412,091 10,417,548 10,444,071 10,416,114 10,374,252 10,359,055 0.35%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin 12.27% 9.75% 9.21% 7.18% 10.27% 10.44% 10.71% -
ROE 6.29% 6.38% 6.09% 5.14% 6.98% 7.28% 7.86% -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 147.65 153.73 161.01 170.37 160.85 163.30 168.08 -8.28%
EPS 8.80 8.55 8.40 7.76 9.80 9.91 10.38 -10.43%
DPS 9.50 0.00 0.00 0.00 9.50 0.00 0.00 -
NAPS 1.40 1.34 1.38 1.51 1.40 1.36 1.32 4.00%
Adjusted Per Share Value based on latest NOSH - 10,444,071
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 138.55 144.21 151.12 160.31 150.96 152.63 156.87 -7.95%
EPS 8.26 8.02 7.88 7.30 9.17 9.26 9.69 -10.10%
DPS 8.91 0.00 0.00 0.00 8.92 0.00 0.00 -
NAPS 1.3136 1.2571 1.2953 1.4209 1.3138 1.2712 1.232 4.37%
Price Multiplier on Financial Quarter End Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 -
Price 1.67 1.64 1.57 1.60 1.55 1.67 1.59 -
P/RPS 1.13 1.07 0.98 0.94 0.96 1.02 0.95 12.27%
P/EPS 18.98 19.19 18.69 20.62 15.87 16.86 15.32 15.36%
EY 5.27 5.21 5.35 4.85 6.30 5.93 6.53 -13.32%
DY 5.69 0.00 0.00 0.00 6.13 0.00 0.00 -
P/NAPS 1.19 1.22 1.14 1.06 1.11 1.23 1.20 -0.55%
Price Multiplier on Announcement Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 25/08/16 26/05/16 25/02/16 26/11/15 20/08/15 21/05/15 12/02/15 -
Price 1.70 1.60 1.56 1.54 1.48 1.65 1.74 -
P/RPS 1.15 1.04 0.97 0.90 0.92 1.01 1.04 6.93%
P/EPS 19.32 18.72 18.57 19.85 15.15 16.66 16.76 9.94%
EY 5.18 5.34 5.38 5.04 6.60 6.00 5.97 -9.03%
DY 5.59 0.00 0.00 0.00 6.42 0.00 0.00 -
P/NAPS 1.21 1.19 1.13 1.02 1.06 1.21 1.32 -5.64%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment